MSB 1.49% $1.02 mesoblast limited

MESO Nasdaq update, page-1537

  1. 3,819 Posts.
    lightbulb Created with Sketch. 359
    he has a low expectation on Revascor phase 3 trial. Why does he have a low expectation?? can he give a reason why?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.